Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 204412 / DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 400MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| MESALAMINE(UNII: 4Q81I59GXC) (MESALAMINE - UNII:4Q81I59GXC) | MESALAMINE | 400mg |
Inactive Ingredients
| Ingredient Name | Allergan, Inc. |
|---|---|
| DIBUTYL SEBACATE(4W5IH7FLNY) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| HYPROMELLOSES(3NXW29V3WO) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2)(5KY68S2577) | |
| POLYETHYLENE GLYCOLS(3WJQ0SDW1A) | |
| POVIDONE(FZ989GH94E) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2) | |
| TALC(7SEV7J4R1U) |
